Literature DB >> 22532933

Two cases of partial hepatectomy for malignant melanoma.

Aaron I Karlen1, Justin J Clark, Linda L Wong.   

Abstract

BACKGROUND: While the liver is a frequent site of metastatic spread for malignant cutaneous as well as malignant ocular melanoma, isolated hepatic metastases without evidence of systemic disease is rare. Hepatic resection has been proposed as a therapeutic and potentially curative procedure in metastatic melanoma patients with isolated hepatic metastases.
OBJECTIVE: To report two metastatic melanoma patients with isolated hepatic metastases treated with partial hepatectomy. In addition, the literature is reviewed and the management and efficacy of surgical excision for isolated hepatic disease in the setting of malignant melanoma is discussed. CASE REPORT: A 34-year-old woman with metastatic cutaneous melanoma and a 55-year-old man with metastatic ocular melanoma are presented. Both patients developed isolated hepatic metastases detected during routine surveillance following resection of their primary disease and underwent partial hepatectomy.
CONCLUSION: In select cases, partial hepatectomy is an efficacious and potentially curative treatment for metastatic melanoma patients with isolated hepatic metastases.

Entities:  

Mesh:

Year:  2012        PMID: 22532933      PMCID: PMC3332119     

Source DB:  PubMed          Journal:  Hawaii J Med Public Health        ISSN: 2165-8242


  33 in total

1.  Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases.

Authors:  U Pastorino; M Buyse; G Friedel; R J Ginsberg; P Girard; P Goldstraw; M Johnston; P McCormack; H Pass; J B Putnam
Journal:  J Thorac Cardiovasc Surg       Date:  1997-01       Impact factor: 5.209

2.  Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy.

Authors:  S Leyvraz; V Spataro; J Bauer; S Pampallona; R Salmon; T Dorval; R Meuli; M Gillet; F Lejeune; L Zografos
Journal:  J Clin Oncol       Date:  1997-07       Impact factor: 44.544

3.  Metastatic ocular and cutaneous melanoma: a comparison of patient characteristics and prognosis.

Authors:  D M Albert; L M Ryan; E C Borden
Journal:  Arch Ophthalmol       Date:  1996-01

4.  Does complete resection of melanoma metastatic to solid intra-abdominal organs improve survival?

Authors:  T F Wood; L A DiFronzo; D M Rose; P I Haigh; S L Stern; L Wanek; R Essner; D L Morton
Journal:  Ann Surg Oncol       Date:  2001-09       Impact factor: 5.344

5.  Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment.

Authors:  S Eskelin; S Pyrhönen; P Summanen; M Hahka-Kemppinen; T Kivelä
Journal:  Ophthalmology       Date:  2000-08       Impact factor: 12.079

Review 6.  Treatment of melanoma metastases confined to the liver and future perspectives.

Authors:  Alexander L Vahrmeijer; Cornelis J H van de Velde; Henk H Hartgrink; Rob A E M Tollenaar
Journal:  Dig Surg       Date:  2009-02-12       Impact factor: 2.588

7.  Screening for metastasis from choroidal melanoma: the Collaborative Ocular Melanoma Study Group Report 23.

Authors:  Marie Diener-West; Sandra M Reynolds; Donna J Agugliaro; Robert Caldwell; Kristi Cumming; John D Earle; Donna L Green; Barbara S Hawkins; James Hayman; Ishmael Jaiyesimi; John M Kirkwood; Wui-Jin Koh; Dennis M Robertson; John M Shaw; Jonni Thoma
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

8.  Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients.

Authors:  S Peters; V Voelter; L Zografos; S Pampallona; R Popescu; M Gillet; W Bosshard; G Fiorentini; M Lotem; R Weitzen; U Keilholz; Y Humblet; S Piperno-Neumann; R Stupp; S Leyvraz
Journal:  Ann Oncol       Date:  2006-02-09       Impact factor: 32.976

9.  Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.

Authors:  A Y Bedikian; S S Legha; G Mavligit; C H Carrasco; S Khorana; C Plager; N Papadopoulos; R S Benjamin
Journal:  Cancer       Date:  1995-11-01       Impact factor: 6.860

10.  Treatment of cutaneous melanoma: current approaches and future prospects.

Authors:  Alain P Algazi; Christopher W Soon; Adil I Daud
Journal:  Cancer Manag Res       Date:  2010-08-17       Impact factor: 3.989

View more
  1 in total

1.  Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases.

Authors:  Marybeth S Hughes; Jonathan Zager; Mark Faries; H Richard Alexander; Richard E Royal; Bradford Wood; Junsung Choi; Kevin McCluskey; Eric Whitman; Sanjiv Agarwala; Gary Siskin; Charles Nutting; Mary Ann Toomey; Carole Webb; Tatiana Beresnev; James F Pingpank
Journal:  Ann Surg Oncol       Date:  2015-11-23       Impact factor: 5.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.